Lung cancer comes in two main types: non-small cell and small cell. Each has different patterns, growth rates, and treatment needs. Smoking is the top risk factor, but…
Harry Erba, MD, PhD, Duke University, Durham, NC; Marina Konopleva, MD, PhD, Albert Einstein College of Medicine, New York City, NY; Thomas Cluzeau, MD, PhD, Central University Hospital…
NEW YORK (Reuters Health) – Compared to conventional white light bronchoscopy, autofluorescence bronchoscopy is more sensitive in detecting lung cancer and preneoplastic lesions, according to a meta-analysis conducted…
NEW YORK (Reuters Health) – Warfarin dosing based on genotype-stratified tables is more accurate than empiric dosing, but not as good as estimates derived from formal pharmacogenetic algorithms,…
NEW YORK (Reuters Health) – Women with polycystic ovary syndrome have increased levels of LDL-cholesterol and non-HDL-cholesterol, as well as more widely recognized alterations in triglycerides and HDL…
NEW YORK (Reuters Health) – A high loading dose of clopidogrel — 600 mg — appears to be unnecessary in Asian patients with ST-segment elevation myocardial infarction (STEMI)…
NEW YORK (Reuters Health) – Stroke events are significantly less likely after carotid endarterectomy than after carotid artery stenting, particularly in the long term and among older patients,…
NEW YORK (Reuters Health) – Neither injectable nor oral contraceptives have a meaningful effect on glucose or insulin levels, researchers report in the January 2011 Obstetrics & Gynecology.…
NEW YORK (Reuters Health) – In comparison with results in adults with diabetes, hemoglobin A1c (HbA1C) testing in younger patients doesn’t have the same level of discrimination, researchers…
NEW YORK (Reuters Health) – The clinical efficacy of rituximab in rheumatoid arthritis (RA) depends on the degree of B cell depletion rather than the dose of rituximab,…
NEW YORK (Reuters Health) – The response rate to high-dose pulsed intravenous glucocorticoid therapy is about 80% for patients with active Graves’ orbitopathy, German clinicians report. However, they…
NEW YORK (Reuters Health) – The transvenous high-voltage leads of Medtronic’s Sprint Fidelis implantable cardioverter-defibrillator continue to deteriorate more rapidly than the earlier Medtronic Quattro Secure ICD leads,…